N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease

被引：0
|
作者：
Gerrits, CMJM [1 ]
Herings, RMC
Leufkens, HGM
Lammers, JWJ
机构：
[1] Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands
[2] PHARMO Inst, Utrecht, Netherlands
[3] Heart Lung Ctr Utrecht, Dept Pulm Dis, Utrecht, Netherlands
来源：
EUROPEAN RESPIRATORY JOURNAL | 2003年 / 22卷 / 05期
关键词：
D O I：
10.1183/09031936.03.00081803
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：865 / 866
页数：2
相关论文
共 50 条
  • [41] A double-blind randomized controlled trial of N-acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease
    Kwok, Wang Chung
    Chan, Shung Kay Samuel
    Chiang, Ka Yan
    Ho, Chung Man James
    RESPIROLOGY CASE REPORTS, 2024, 12 (08):
  • [42] N-acetylcysteine in chronic blepharitis
    Yalçin, E
    Altin, F
    Cinhüseyinoglue, F
    Arslan, MO
    CORNEA, 2002, 21 (02) : 164 - 168
  • [43] Do community hospice programmes reduce hospitalisation rate in patients with advanced chronic obstructive pulmonary disease?
    Iupati, S. P. M.
    Ensor, B. R.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (03) : 295 - 300
  • [44] Physical inactivity and risk of hospitalisation for chronic obstructive pulmonary disease
    Seidel, D.
    Cheung, A.
    Suh, E-S.
    Raste, Y.
    Atakhorrami, M.
    Spruit, M. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (08) : 1015 - 1019
  • [45] N-Acetylcysteine may reduce risk of heart disease in patients with diabetes
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2012, 14 (11): : 1058 - 1058
  • [46] Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
    Paola Rogliani
    Maria Gabriella Matera
    Clive Page
    Ermanno Puxeddu
    Mario Cazzola
    Luigino Calzetta
    Respiratory Research, 20
  • [47] Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?
    Ringbaek, TJ
    Viskum, K
    Lange, P
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (01) : 38 - 42
  • [48] Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
    Hernandez, C
    Casas, A
    Escarrabill, J
    Alonso, J
    Puig-Junoy, J
    Farrero, E
    Vilagut, G
    Collvinent, B
    Rodriguez-Roisin, R
    Roca, J
    EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (01) : 58 - 67
  • [49] Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
    Rogliani, Paola
    Matera, Maria Gabriella
    Page, Clive
    Puxeddu, Ermanno
    Cazzola, Mario
    Calzetta, Luigino
    RESPIRATORY RESEARCH, 2019, 20 (1)
  • [50] Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease
    Jones, AL
    Jarvie, DR
    Simpson, D
    Hayes, PC
    Prescott, LF
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (04) : 787 - 791
12345